title: Ketamine in critical illness: another no-NO agent?
authors.forename: Martin
authors.initials: M
authors.lastname: Westphal
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Traber
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D006801:Humans; D007649:Ketamine / Q000494:pharmacology*; D008833:Microcirculation / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D052250:Nitric Oxide Synthase Type III; D018805:Sepsis / Q000378:metabolism*
chemical_list: D000700:Analgesics; D009569:Nitric Oxide; D007649:Ketamine; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III